Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Prime Medicine (PRME) Other Non Operating Income (2021 - 2025)

Prime Medicine filings provide 5 years of Other Non Operating Income readings, the most recent being $49000.0 for Q4 2025.

  • On a quarterly basis, Other Non Operating Income rose 13.95% to $49000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $148000.0, a 260.98% increase, with the full-year FY2025 number at $148000.0, up 260.98% from a year prior.
  • Other Non Operating Income hit $49000.0 in Q4 2025 for Prime Medicine, up from $44000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $2.1 million in Q1 2023 to a low of -$83000.0 in Q3 2024.
  • Median Other Non Operating Income over the past 5 years was $42500.0 (2023), compared with a mean of $248333.3.
  • Biggest five-year swings in Other Non Operating Income: surged 72900.0% in 2022 and later tumbled 293.02% in 2024.
  • Prime Medicine's Other Non Operating Income stood at $12000.0 in 2021, then skyrocketed by 7616.67% to $926000.0 in 2022, then tumbled by 84.02% to $148000.0 in 2023, then tumbled by 70.95% to $43000.0 in 2024, then rose by 13.95% to $49000.0 in 2025.
  • The last three reported values for Other Non Operating Income were $49000.0 (Q4 2025), $44000.0 (Q3 2025), and $18000.0 (Q2 2025) per Business Quant data.